newsfilter
← Latest News
PR Newswire·

CTI BioPharma Presents Pivotal Data from Pacritinib Program at the European Hematology Association (EHA) 2022 Congress

SEATTLE, June 10, 2022 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ:CTIC) today announced two scientific poster presentations from the Company's pacritinib clinical program at the European Hematology Association (EHA) 2022 Congress, being held in Vienna,